FDA Approves Imaging Drug for Detecting Ovarian Cancer Lesions FDA Approves Imaging Drug for Detecting Ovarian Cancer Lesions

The tumor-targeted agent pafolacianine causes ovarian cancer lesions to ' light up like stars against a night sky ' and improve surgeons ' ability to locate cancerous tissue.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news